Diabetes Mellitus, Type 2
Showing NaN - NaN of 183
Diabetes, Type 2 Trial in Worldwide (Semaglutide, Empagliflozin, Metformin)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Semaglutide
- +2 more
-
Toluca Lake, California
- +101 more
Oct 9, 2023
Diabetes, Type 2, Peripheral Arterial Disease Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Recruiting
- Diabetes Mellitus, Type 2
- Peripheral Arterial Disease
- Semaglutide
- Placebo (semaglutide)
-
Birmingham, Alabama
- +179 more
Jan 23, 2023
Obesity, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo)
Recruiting
- Obesity
- Diabetes Mellitus, Type 2
- Semaglutide
- Placebo
-
Birmingham, Alabama
- +73 more
Jan 24, 2023
Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Active, not recruiting
- Diabetes Mellitus, Type 2
- Semaglutide
- Placebo (semaglutide)
-
Tuscumbia, Alabama
- +393 more
Jan 17, 2023
Diabetes, Type 2, Chronic Kidney Disease Trial in Worldwide (Semaglutide, Placebo (Semaglutide))
Recruiting
- Diabetes Mellitus, Type 2
- Chronic Kidney Disease
- Semaglutide
- Placebo (Semaglutide)
-
Tucson, Arizona
- +33 more
Jan 17, 2023
Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Placebo insulin icodec, Insulin degludec)
Completed
- Diabetes Mellitus, Type 2
- Insulin icodec
- +3 more
-
Guntersville, Alabama
- +91 more
Nov 11, 2022
Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Insulin Glargine 100U/mL, Insulin Degludec)
Completed
- Diabetes Mellitus, Type 2
- Insulin icodec
- +3 more
-
Birmingham, Alabama
- +178 more
Nov 3, 2022
Diabetes, Type 2 Trial in Worldwide (Linagliptin, Empagliflozin, Placebo)
Active, not recruiting
- Diabetes Mellitus, Type 2
- Linagliptin
- +2 more
-
Phoenix, Arizona
- +82 more
Aug 23, 2022
Diabetes, Type 2 Trial in Worldwide (Canagliflozin 100 mg, Canagliflozin 300 mg, Placebo)
Recruiting
- Diabetes Mellitus, Type 2
- Canagliflozin 100 mg
- +2 more
-
Little Rock, Arkansas
- +121 more
Aug 18, 2022
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, empagliflozin)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
-
Tuscumbia, Alabama
- +105 more
Jul 11, 2022
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- placebo
-
Lancaster, California
- +104 more
Jul 11, 2022
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- +2 more
-
Birmingham, Alabama
- +107 more
Jul 11, 2022
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, sitagliptin, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- +2 more
-
Anniston, Alabama
- +241 more
Jul 11, 2022
Diabetes, Type 2 Trial in Worldwide (Metformin DR, Metformin IR, Metformin DR Placebo)
Recruiting
- Diabetes Mellitus, Type 2
- Metformin DR
- +3 more
-
Glendale, Arizona
- +86 more
Jun 7, 2022
Diabetes, Type 2 Trial in Worldwide (Oral semaglutide)
Active, not recruiting
- Diabetes Mellitus, Type 2
- Oral semaglutide
-
Buena Park, California
- +177 more
Mar 31, 2022
Diabetes, Type 2 Trial in Worldwide (NNC0480-0389, Semaglutide, Placebo (NNC080-0389))
Recruiting
- Diabetes Mellitus, Type 2
- NNC0480-0389
- +3 more
-
Buena Park, California
- +95 more
Mar 31, 2022
Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in United States (Eversense® CGM system)
Active, not recruiting
- Diabetes Mellitus
- +2 more
- Eversense® CGM system
-
Newport Beach, California
- +16 more
Mar 31, 2022
Diabetes, Type 2 Trial in Worldwide (Insulin degludec, Insulin Icodec)
Completed
- Diabetes Mellitus, Type 2
- Insulin degludec
- Insulin Icodec
-
Buena Park, California
- +71 more
Mar 29, 2022
Diabetes, Type 2 Trial in Worldwide (Alogliptin Benzoate, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Alogliptin Benzoate
- Placebo
-
Little Rock, Arkansas
- +54 more
Mar 14, 2022
Obesity, Hypertension, Diabetes, Type 2 Trial in United States (Overstitch)
Completed
- Obesity
- +2 more
- Overstitch
-
Orlando, Florida
- +8 more
Mar 14, 2022
Diabetes, Type 2 Trial in United States (Semaglutide 2.4 mg, Cagrilintide 2.4 mg, Placebo (semaglutide))
Active, not recruiting
- Diabetes Mellitus, Type 2
- Semaglutide 2.4 mg
- +3 more
-
Birmingham, Alabama
- +17 more
Mar 14, 2022
Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Active, not recruiting
- Diabetes Mellitus, Type 2
- Semaglutide
- Placebo (semaglutide)
-
Montgomery, Alabama
- +444 more
Mar 11, 2022
Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Completed
- Diabetes Mellitus, Type 2
- Semaglutide
- Placebo (semaglutide)
-
Birmingham, Alabama
- +128 more
Feb 14, 2022
Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin degludec, Insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Insulin degludec
- Insulin glargine
-
Anniston, Alabama
- +228 more
Jan 6, 2022